Enjoy complimentary customisation on priority with our Enterprise License!
The sulphonamides market size is forecast to increase by USD 123.4 million at a CAGR of 4.5% between 2023 and 2028. The market is witnessing significant growth due to the rising prevalence of infectious diseases and increasing awareness of various diseases and their treatment. The market is driven by the high demand for sulphonamides in the pharmaceutical industry for the production of antibiotics, antipyretics, and antiprotozoal agents. However, decreased investments in research activities pose a challenge to the market's growth. Additionally, the emergence of alternative treatments and increasing resistance to sulphonamides among pathogens are other significant challenges. Despite these challenges, the market is expected to grow at a steady pace due to the large patient population suffering from infectious diseases and the effectiveness of sulphonamides in treating various infections.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Formulation
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.